120 related articles for article (PubMed ID: 21657827)
1. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
[TBL] [Abstract][Full Text] [Related]
2. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization.
van Eeden PE; Tee LB; Lukehurst S; Lai CM; Rakoczy EP; Beazley LD; Dunlop SA
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462
[TBL] [Abstract][Full Text] [Related]
3. VEGF-induced choroidal damage in a murine model of retinal neovascularisation.
Tee LB; Penrose MA; O'Shea JE; Lai CM; Rakoczy EP; Dunlop SA
Br J Ophthalmol; 2008 Jun; 92(6):832-8. PubMed ID: 18523088
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
5. Generation of transgenic mice with mild and severe retinal neovascularisation.
Lai CM; Dunlop SA; May LA; Gorbatov M; Brankov M; Shen WY; Binz N; Lai YK; Graham CE; Barry CJ; Constable IJ; Beazley LD; Rakoczy EP
Br J Ophthalmol; 2005 Jul; 89(7):911-6. PubMed ID: 15965177
[TBL] [Abstract][Full Text] [Related]
6. Angiography reveals novel features of the retinal vasculature in healthy and diabetic mice.
McLenachan S; Magno AL; Ramos D; Catita J; McMenamin PG; Chen FK; Rakoczy EP; Ruberte J
Exp Eye Res; 2015 Sep; 138():6-21. PubMed ID: 26122048
[TBL] [Abstract][Full Text] [Related]
7. rAAV.sFlt-1 gene therapy achieves lasting reversal of retinal neovascularization in the absence of a strong immune response to the viral vector.
Lai CM; Estcourt MJ; Wikstrom M; Himbeck RP; Barnett NL; Brankov M; Tee LB; Dunlop SA; Degli-Esposti MA; Rakoczy EP
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4279-87. PubMed ID: 19357358
[TBL] [Abstract][Full Text] [Related]
8. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
[TBL] [Abstract][Full Text] [Related]
9. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
Zhang M; Yang Y; Yan M; Zhang J
Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
[TBL] [Abstract][Full Text] [Related]
11. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
12. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
13. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors.
Tobe T; Okamoto N; Vinores MA; Derevjanik NL; Vinores SA; Zack DJ; Campochiaro PA
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560
[TBL] [Abstract][Full Text] [Related]
14. Low power laser treatment of the retina ameliorates neovascularisation in a transgenic mouse model of retinal neovascularisation.
Yu PK; Cringle SJ; McAllister IL; Yu DY
Exp Eye Res; 2009 Nov; 89(5):791-800. PubMed ID: 19615996
[TBL] [Abstract][Full Text] [Related]
15. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
17. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a mouse model of hyperglycemia and retinal neovascularization.
Rakoczy EP; Ali Rahman IS; Binz N; Li CR; Vagaja NN; de Pinho M; Lai CM
Am J Pathol; 2010 Nov; 177(5):2659-70. PubMed ID: 20829433
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of interfering RNA targeting HIF-1alpha and VEGF on retinal neovascularization in the mouse].
Jiang J; Xia XB; Xu HZ; Xiong Y; Song WT; Xiong SQ; Li Y
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):921-8. PubMed ID: 19176122
[TBL] [Abstract][Full Text] [Related]
20. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
